Bergstrand M - Search Results

1

PBPK models for the prediction of in vivo performance of oral dosage forms.

Kostewicz ES, Aarons L, Bergstrand M, Bolger MB, Galetin A, Hatley O, Jamei M, Lloyd R, Pepin X, Rostami-Hodjegan A, Sjögren E, Tannergren C, Turner DB, Wagner C, Weitschies W, Dressman J. Kostewicz ES, et al. Among authors: bergstrand m. Eur J Pharm Sci. 2014 Jun 16;57:300-21. doi: 10.1016/j.ejps.2013.09.008. Epub 2013 Sep 21. Eur J Pharm Sci. 2014. PMID: 24060672 Review.

2

A semi-mechanistic modeling strategy for characterization of regional absorption properties and prospective prediction of plasma concentrations following administration of new modified release formulations.

Bergstrand M, Söderlind E, Eriksson UG, Weitschies W, Karlsson MO. Bergstrand M, et al. Pharm Res. 2012 Feb;29(2):574-84. doi: 10.1007/s11095-011-0595-2. Epub 2011 Sep 23. Pharm Res. 2012. PMID: 21948384

3

A semi-mechanistic modeling strategy to link in vitro and in vivo drug release for modified release formulations.

Bergstrand M, Söderlind E, Eriksson UG, Weitschies W, Karlsson MO. Bergstrand M, et al. Pharm Res. 2012 Mar;29(3):695-706. doi: 10.1007/s11095-011-0594-3. Epub 2011 Sep 27. Pharm Res. 2012. PMID: 21948457 Clinical Trial.

4

Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions.

Hénin E, Bergstrand M, Weitschies W, Karlsson MO. Hénin E, et al. Among authors: bergstrand m. Pharm Res. 2016 Mar;33(3):751-62. doi: 10.1007/s11095-015-1824-x. Epub 2015 Nov 9. Pharm Res. 2016. PMID: 26553354

5

Mechanistic modeling of a magnetic marker monitoring study linking gastrointestinal tablet transit, in vivo drug release, and pharmacokinetics.

Bergstrand M, Söderlind E, Weitschies W, Karlsson MO. Bergstrand M, et al. Clin Pharmacol Ther. 2009 Jul;86(1):77-83. doi: 10.1038/clpt.2009.43. Epub 2009 Apr 22. Clin Pharmacol Ther. 2009. PMID: 19387437

6

In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status.

Guiastrennec B, Söderlind E, Richardson S, Peric A, Bergstrand M. Guiastrennec B, et al. Among authors: bergstrand m. Pharm Res. 2017 Apr;34(4):847-859. doi: 10.1007/s11095-017-2113-7. Epub 2017 Feb 2. Pharm Res. 2017. PMID: 28155077 Free PMC article.

7

A mechanism-based approach for absorption modeling: the Gastro-Intestinal Transit Time (GITT) model.

Hénin E, Bergstrand M, Standing JF, Karlsson MO. Hénin E, et al. Among authors: bergstrand m. AAPS J. 2012 Jun;14(2):155-63. doi: 10.1208/s12248-012-9324-y. AAPS J. 2012. PMID: 22286919 Free PMC article.

8

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Bergstrand M, et al. AAPS J. 2011 Jun;13(2):143-51. doi: 10.1208/s12248-011-9255-z. Epub 2011 Feb 8. AAPS J. 2011. PMID: 21302010 Free PMC article.

9

Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.

Wallin JE, Bergstrand M, Wilczek HE, Nydert PS, Karlsson MO, Staatz CE. Wallin JE, et al. Among authors: bergstrand m. Ther Drug Monit. 2011 Dec;33(6):663-72. doi: 10.1097/FTD.0b013e31823415cc. Ther Drug Monit. 2011. PMID: 22105583

10

Serial correlation in optimal design for nonlinear mixed effects models.

Nyberg J, Höglund R, Bergstrand M, Karlsson MO, Hooker AC. Nyberg J, et al. Among authors: bergstrand m. J Pharmacokinet Pharmacodyn. 2012 Jun;39(3):239-49. doi: 10.1007/s10928-012-9245-5. Epub 2012 Mar 14. J Pharmacokinet Pharmacodyn. 2012. PMID: 22415637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page